Search
-
The Joan Massagué Lab
… Job Title Associate Professor, Center for Advanced Biotechnology & Medicine, Rutgers Cancer Institute, NJ Degree PhD Start Year 1993 End Year 1998 Email [email protected]
-
The Daniel Heller Lab
… Job Title Patent Law Clerk at Foley Lardner LLP and JD Candidate Education BA in Chemistry
-
Video
Dr. Jamie Chaft treats early-stage lung cancer, including non-small cell, at MSK in Manhattan and MSK Monmouth, providing custom treatment plans and clinical trials.
… Dr. Jamie Chaft treats early-stage lung cancer, including non-small cell, at MSK in Manhattan and MSK Monmouth, providing custom treatment plans and clinical trials. As the Director of Early Stage Lung Cancer Research, I’m deeply invested in the personalization of curative lung cancer care. For my patients
-
Clinical Trial
… Full Title Phase 2 Study of the Combination of Lisocabtagene Maraleucel, Nivolumab, and Ibrutinib in Richter’s Transformation Purpose When people have Richter’s transformation, their chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) changes into a more aggressive disease. Researchers
-
-
Technology Development
… SK 784 Description Calu-1 is a non-small-cell lung cancer (NSCLC) cell line that grows in adherent culture and displays epithelial morphology. These cells express wildtype LKB1, wildtype EGFR, and mutant K-Ras (G12C). In addition, they lack expression of both p53 (homozygous deletion) and FHIT (Fragile
-
Technology Development
… SK2022-124 SUMMARY OF INVENTION MSK investigators have developed a novel platform of vector-encoded NFAT and NFκB inhibitors that significantly enhance CAR T-cell therapy by addressing two critical barriers: T-cell exhaustion and treatment-related toxicity. The technology employs engineered calcineurin
-
Clinical Trial
… Full Title A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (CaMMouflage Trial) Purpose Researchers want to find the best dose of CB-011 to treat multiple myeloma. The people in this study
-
Radiation therapy for esophageal cancer is used to shrink or get rid of tumors.
… Radiation therapy for esophageal cancer is the use of high-energy beams to shrink or get rid of tumors. Memorial Sloan Kettering has been a leader in improving radiation therapy for esophageal cancer. We have developed tools to deliver powerful doses of radiation to tumors with precision. Our radiation
-
The Sunitha Thakur Lab
Medical physicist Sunitha Thakur focuses on MR biomarkers for early detection and monitoring response to treatment.
… I am an assistant attending physicist in the Departments of Medical Physics and Radiology, where I collaborate with radiologists, neurologists, and physicists to develop and validate new magnetic resonance (MR) biomarkers to aid in the early detection of cancer, identify aggressive tumor growth, and